Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (5): 836-844. doi: 10.19723/j.issn.1671-167X.2020.05.007

Previous Articles     Next Articles

Comparison study of whole exome sequencing and targeted panel sequencing in molecular diagnosis of inherited retinal dystrophies

Xiao-zhen LIU,Ying-ying LI,Li-ping YANG()   

  1. Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China
  • Received:2018-11-27 Online:2020-10-18 Published:2020-10-15
  • Contact: Li-ping YANG E-mail:alexlipingyang@bjmu.edu.cn
  • Supported by:
    National Natural Science Foundation of China(81470666);National Natural Science Foundation of China(81770966)

Abstract:

Objective: To evaluate and compare whole exome sequencing (WES) and targeted panel sequencing in the clinical molecular diagnosis of the Chinese families affected with inherited retinal dystrophies (IRDs). Methods: The clinical information of 182 probands affected with IRDs was collected, including their family history and the ophthalmic examination results. Blood samples of all probands and their relatives were collected and genomic DNA was extracted by standard protocols. The first 91 cases were subjected to the WES and the other 91 cases were subjected to a specific hereditary eye disease enrichment panel (HEDEP) designed by us. All likely pathogenic and pathogenic variants in the candidate genes were determined by Sanger sequencing and co-segregation analyses were performed in available family members. Copy number variations (CNVs) detected by HEDEP were further validated by multiplex ligation-dependent probe amplification (MLPA). As PRGR ORF15 was difficult to capture by next generation sequencing (NGS), all the samples were subjected to Sanger sequencing for this region. All sequence changes identified by NGS were classified according to the American College of Medical Gene-tics and Genomics and the Association for Molecular Pathology (ACMG/AMP) variant interpretation guidelines. In this study, only variants identified as pathogenic or likely pathogenic were included, while those variants of uncertain significance, likely benign or benign were not included. Results: In 91 cases with WES, pathogenic or likely pathogenic variants were determined in 30 cases, obtaining a detection rate of 33.00% (30/91); While in 91 cases with HEDEP sequencing, pathogenic or likely pathogenic variants were determined in 51 cases, achieving the diagnostic rate of 56.04% (51/91), and totally, the diagnostic rate was 44.51%. HEDEP had better sequencing coverage and read depth than WES, therefore HEDEP had higher detection rate. In addition, HEDEP could detect CNVs. In this study, we detected disease-causing variants in 29 distinct IRD-associated genes, USH2A, ABCA4 and RPGR were the three most common disease-causing genes, and the frequency of these genes in Chinese IRDs population was 11.54% (21/182), 6.59% (12/182) and 3.85% (7/182), respectively. We found 43 novel variants and 6 cases carried variants in RPGR ORF15. Conclusion: NGS in conjunction with Sanger sequencing offers a reliable and effective approach for the genetic diagnosis of IRDs, and after evaluating the pros and cons of the two sequencing methods, we conclude that HEDEP should be used as a first-tier test for IRDs patients, WES can be used as a supplementary molecular diagnostic method due to its merit of detecting novel IRD-associated genes if HEDEP or other methods could not detect disease-causing va-riants in reported genes. In addition, our results enriched the mutational spectra of IRDs genes, and our methods paves the way of genetic counselling, family planning and up-coming gene-based therapies for these families.

Key words: Inherited retinal dystrophies, Whole exome sequencing, Hereditary eye disease enrichment panel, Variation

CLC Number: 

  • R774.13

Figure 1

The clinical information of 182 IRDs families A, the clinical diagnosis results of 182 Chinses IRDs families; B, the percentage of different inheritance modes in this study. RP, retinitis pigmentosa; CORD, cone rod dystrophies; LCA, Leber congenital amaurosis; USH, Usher syndrome; STGD, Stargardt disease; BBS, Bardet-Biedl syndrome; BCD, Bietti crystalline corneoretinal dystrophy; MD, macular degeneration; CHM, choroideremia; AR, autosomal recessive; AD, autosomal dominant; XL, X-linked."

Figure 2

(Likely) pathogenic variants in 29 IRDs-associated genes of 81 families were genetically diagnosed AR, autosomal recessive; AD, autosomal dominant; XL, X-linked. "

Figure 3

Pathogenic mutations of ABCA4 identified in patient 1 A, the pedigree of patient 1; B, representative sequence chromatograms for the proband and her father validated by Sanger sequencing; C, representative sequence analysis results for the proband and her mother validated by MLPA. "

Figure 4

Sequencing coverage comparison of HEDEP and WES The Y-axis indicates the fraction of target base pairs that had at least 1×, 5×, 10×, 20×, 50×, 100× for each sample, respectively. The X-axis indicates the sequencing coverage of HEDEP or WES. The red full line represents HEDEP, the blue dotted line represents WES. "

Figure 5

The clinical examination and genetic diagnosis result of patient 2 A, fundus examination showed the symptoms of RP; B, the pedigree of patient 2; C, representative sequence chromatograms for the proband and his parents validated by Sanger sequencing. "

Figure 6

The clinical examination and genetic diagnosis result of patient 3 A, Fundus examination showed the symptoms of late stage Bietti crystalline corneoretinal dystrophy (BCD); B, The pedigree of patient 3; C, Representative sequence chromatograms for the proband and his father validated by Sanger sequencing. "

Figure 7

Flow diagram of the genetic diagnosis of IRDs cases"

[1] Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases[J]. Prog Retin Eye Res, 2010,29(5):335-375.
doi: 10.1016/j.preteyeres.2010.03.004
[2] Zhao L, Wang F, Wang H, et al. Next-generation sequencing-based molecular diagnosis of 82 retinitis pigmentosa probands from Northern Ireland[J]. Hum Genet, 2015,134(2):217-230.
doi: 10.1007/s00439-014-1512-7 pmid: 25472526
[3] Glockle N, Konl LS, Mohr J, et al. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies[J]. Eur J Hum Genet, 2014,22(1):99-104.
doi: 10.1038/ejhg.2013.72
[4] Beryozkin A, Shevah E, Kimchi A, et al. Whole exome sequencing reveals mutations in known retinal disease genes in 33 out of 68 Israeli families with inherited retinopathies[J]. Sci Rep, 2015(5):13187.
[5] Yang L, Cui H, Yin X, et al. Dependable and efficient clinical molecular diagnosis of Chinese RP patient with targeted exon sequencing[J]. PLoS One, 2015,10(10):e0140684.
doi: 10.1371/journal.pone.0140684 pmid: 26496393
[6] Riera M, Navarro R, Ruiz-Nogales S, et al. Whole exome sequencing using Ion Proton system enables reliable genetic diagnosis of inherited retinal dystrophies[J]. Sci Rep, 2017(7):42078.
[7] Zhang J, Wang C, Shen Y, et al. A mutation in ADIPOR1 causes nonsyndromic autosomal dominant retinitis pigmentosa[J]. Hum Genet, 2016,135(12):1375-1387.
doi: 10.1007/s00439-016-1730-2 pmid: 27655171
[8] Bader I, Brandau O, Achatz H, et al. X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15[J]. Invest Ophthalmol Vis Sci, 2003,44(4):1458-1463.
doi: 10.1167/iovs.02-0605 pmid: 12657579
[9] Li L, Xiao X, Li S, et al. Detection of variants in 15 genes in 87 unrelated Chinese patients with Leber congenital amaurosis[J]. PLoS One, 2011,6(5):e19458.
doi: 10.1371/journal.pone.0019458 pmid: 21602930
[10] Xiao X, Mai G, Li S, et al. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy[J]. Biochem Biophys Res Commun, 2011,409(2):181-186.
doi: 10.1016/j.bbrc.2011.04.112 pmid: 21565171
[11] Li A, Jiao X, Munier FL, et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2[J]. Am J Hum Genet, 2004,74(5):817-826.
doi: 10.1086/383228
[12] Consugar MB, Navarro-Gomez D, Place EM, et al. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing[J]. Genet Med, 2015,17(4):253-261.
doi: 10.1038/gim.2014.172 pmid: 25412400
[13] Bujakowska KM, Fernandez-Godino R, Place E, et al. Copy-number variation is an important contributor to the genetic causality of inherited retinal degenerations[J]. Genet Med, 2017,19(6):643-651.
doi: 10.1038/gim.2016.158 pmid: 27735924
[14] Haer-Wigman L, van Zelst-Stams WA, Pfundt R, et al. Diagnostic exome sequencing in 266 Dutch patients with visual impairment[J]. Eur J Hum Genet, 2017,25(5):591-599.
doi: 10.1038/ejhg.2017.9 pmid: 28224992
[15] Broadgate S, Yu J, Downes SM, et al. Unravelling the genetics of inherited retinal dystrophies: Past, present and future[J]. Prog Retin Eye Res, 2017(59):53-96.
[16] 周雪莹, 于志强. 全基因组外显子测序在眼科遗传病中的应用[J]. 中华眼科杂志, 2015,51(5):395-400.
[17] ACMG Board of Directors Points to consider in the clinical application of genomic sequencing[J]. Genet Med, 2012,14(8):759-761.
doi: 10.1038/gim.2012.74 pmid: 22863877
[18] Yuzawa M, Mae Y, Matsui M. Bietti’s crystalline retinopathy[J]. Ophthalmic Paediatr Genet, 1986,7(1):9-20.
doi: 10.3109/13816818609058037 pmid: 3703493
[19] Lee KY, Koh AH, Aung T, et al. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations[J]. Invest Ophthalmol Vis Sci, 2005,46(10):3812-3816.
pmid: 16186368
[20] Tiwari A, Lemke J, Altmueller J, et al. Identification of novel and recurrent disease-causing mutations in retinal dystrophies using whole exome sequencing (WES): Benefits and limitations[J]. PLoS One, 2016,11(7):e0158692.
doi: 10.1371/journal.pone.0158692 pmid: 27391102
[1] Ya-fei LIU,Lin-lin SONG,Mao-wei XING,Li-xin CAI,Dong-xin WANG. Comparison of pulse pressure variation, stroke volume variation, and plethysmographic variability index in pediatric patients undergoing craniotomy [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 946-951.
[2] FENG Ke,NI Jing-jing,XIA Yan-qing,QU Xiao-wei,ZHANG Hui-juan,WAN Feng,HONG Kai,ZHANG Cui-lian,GUO Hai-bin. Genetic analysis of three cases of acephalic spermatozoa syndrome caused by SUN5 mutation and the outcome of assisted reproductive technology [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 803-807.
[3] WU Kai1 ZHANG Yang, ZHANG Hong, TAN Zeng-huan2 GUO Xiao-hui, YANG Jian-mei. Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 634-639.
[4] XIE Gao-Qiang-1△, YU Hui-2, CHEN Jing-Zhou-2, ZHAO Lian-Cheng-3△, REN Fu-Xiu-4, SHI Ping-4, WU Yang-Feng-1, 5 , 6 . Relationship of genetic variants and cardiovascular risk factors with interleukin-6 and interleukin-10 secreted by monocytes [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 589-595.
[5] ZHANG Jia-ni, SHI Tie-mei. Reliability of antral follicle counts using transvaginal two- and three- dimensional sonography [J]. Journal of Peking University(Health Sciences), 2013, 45(6): 896-900.
[6] ZHEN Xiu-mei, SUN Yi-min, QIAO Jie, LI Rong, WANG Li-na, LIU Ping . Genome-wide copy number scan in Chinese patients with premature ovarian failure [J]. Journal of Peking University(Health Sciences), 2013, 45(6): 841-847.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 516 -520 .